Company
Auris Health
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
8
510(k), De Novo and PMA
Device trials
8
As lead sponsor, any status
Adverse event reports
47
Received Nov 1, 2025 to Nov 20, 2026
Recall records
8
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$205M
1 Form D offering, 2018 to 2018
Equity
$205M
Stock sold for cash
Debt and convertible notes
$0
Loans and notes sold to investors
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $205M raised of $220M sought, first sale Nov 13, 2018, 22 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2018 | Equity | $205M | $220M | 22 | Rule 506(b)Agent: Allen & Company LLCCommissions $4.5M | Form D ↗Nov 28, 2018 |
Company details
From the company's latest Form D.
- Legal name
- AURIS HEALTH, INC.
- Headquarters
- Redwood City, California
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Technology
- SEC filer
- CIK 1464814 ↗
Executives, directors and promoters
As listed on the latest Form D.
6 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.
No 5%+ shareholder filings, SBIR grants or venture investors found under the name Auris Health.
Latest FDA decisions
K260382 · Decided Jul 25, 2026 · 170 days after receipt
Device type: Bronchoscope (Flexible Or Rigid) (EOQ) · Otolaryngology (ENT)
7 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT06709261 · 32 participants · Start Feb 5, 2025 · Primary completion Oct 20, 2025
Device: OTTAVA Robotic System · For: Obesity
Sites: Orlando, Florida; Tampa, Florida; Indianapolis, Indiana · 6 sites in all
7 more trials with a free account
Reports received
47
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
6
13% of reports
Injury reports
39
83% of reports
Death reports
2
4.3% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 7 | 0 | 0 |
| Jan 24 | 3 | 1 | 0 | 0 |
| Feb 24 | 1 | 3 | 0 | 0 |
| Mar 24 | 1 | 5 | 0 | 0 |
| Apr 24 | 0 | 1 | 0 | 0 |
| May 24 | 0 | 3 | 0 | 0 |
| Jun 24 | 0 | 3 | 0 | 0 |
| Jul 24 | 2 | 2 | 0 | 0 |
| Aug 24 | 1 | 0 | 0 | 0 |
| Sep 24 | 2 | 0 | 0 | 0 |
| Oct 24 | 3 | 1 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 4 | 0 | 0 | 0 |
| Jan 25 | 0 | 1 | 0 | 0 |
| Feb 25 | 0 | 2 | 1 | 0 |
| Mar 25 | 0 | 3 | 0 | 0 |
| Apr 25 | 0 | 8 | 0 | 0 |
| May 25 | 0 | 3 | 0 | 0 |
| Jun 25 | 1 | 4 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 4 | 0 | 0 |
| Sep 25 | 0 | 2 | 0 | 0 |
| Oct 25 | 12 | 1 | 0 | 0 |
| Nov 25 | 1 | 1 | 1 | 0 |
| Dec 25 | 0 | 4 | 0 | 0 |
| Jan 26 | 2 | 2 | 0 | 0 |
| Feb 26 | 0 | 10 | 1 | 0 |
| Mar 26 | 1 | 2 | 0 | 0 |
| Apr 26 | 0 | 3 | 0 | 0 |
| May 26 | 1 | 8 | 0 | 0 |
| Jun 26 | 1 | 5 | 0 | 0 |
| Jul 26 | 0 | 1 | 0 | 0 |
| Aug 26 | 0 | 1 | 0 | 0 |
| Sep 26 | 0 | 1 | 0 | 0 |
| Oct 26 | 0 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
The full in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
2 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- MONARCH Platform, Bronchoscopy, Catalog Numbers: MON-000005-01 , MON-000005-01R , MON-000006 , MON-000006-RFB, MON-000008 with softwareOpen, Classified
Z-1383-2026 · Started Jan 21, 2026 · Posted by FDA Feb 17, 2026
Reason given: Device for bronchoscopic visualization, patient airway access has software issue: if application restarts after patient-side selection, prior to bronchoscope loading, application will re-initialize to patient-left position; and if right position was previously selected, this may lead to unanticipated robotic arm...
Cause as FDA categorized it: Software design · Device type: Bronchoscope (Flexible Or Rigid) (EOQ)
7 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.